Home › NDC Lookup › RxCUI directory › RxCUI 402109

Fosamprenavir 700 MG Oral Tablet — RxCUI 402109

RxNorm drug concept · Semantic clinical drug
RxCUI 402109 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI402109
Official nameFosamprenavir 700 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asfosamprenavir (as fosamprenavir calcium) 700 MG (amprenavir 600 MG) Oral Tablet; fosamprenavir calcium 700 MG Oral Tablet
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fosamprenavir: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats HIV-1 infection. You take it together with other HIV medicines, not by itself. It blocks an enzyme the virus needs to make working copies of itself.
  • Tablets can be taken with or without food. If you or your child uses the oral suspension, adults should take it without food and children should take it with food. If a child vomit...
  • The most common are diarrhea, rash, nausea, vomiting and headache. Mild rashes often settle. But call your doctor right away for a severe rash, blistering, or rash with fever or fe...
  • Not always. Fosamprenavir interacts with many drugs, and some combinations are not allowed, including simvastatin, lovastatin, rifampin and St. John's wort. Always check with me be...
📖 Read our full Fosamprenavir guide →

🕸️ Concept Web — How Fosamprenavir 700 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Fosamprenavir 700 MG Oral Tablet RxCUI 402109

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Fosamprenavir 358262
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lexiva 402108
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fosamprenavir Oral Tablet 402366
    • Fosamprenavir Oral Product 1165665
    • Fosamprenavir Pill 1165666
    • Fosamprenavir Oral Tablet [Lexiva] 402367
    • Lexiva Oral Product 1186157
    • Lexiva Pill 1186158
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Fosamprenavir 700 MG 402364
    • Fosamprenavir 700 MG Oral Tablet [Lexiva] 402110
    • Fosamprenavir 700 MG [Lexiva] 576110

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Fosamprenavir 700 MG SCDC · 402364
  • Fosamprenavir Oral Tablet SCDF · 402366
  • Fosamprenavir Oral Product SCDG · 1165665
  • Fosamprenavir Pill SCDG · 1165666

Brand-Name Concepts

  • Fosamprenavir 700 MG Oral Tablet [Lexiva] SBD · 402110
  • Fosamprenavir 700 MG [Lexiva] SBDC · 576110
  • Fosamprenavir Oral Tablet [Lexiva] SBDF · 402367
  • Lexiva Oral Product SBDG · 1186157
  • Lexiva Pill SBDG · 1186158
  • Lexiva BN · 402108

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 402109 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00378-3520-91 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-3520-91) Fosamprenavir Calcium Mylan Pharmaceuticals Inc. 2017-09-18
Observed labelers: Mylan Pharmaceuticals Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.